RARE BIRD FOUNDATION Working with our partners worldwide , Rare Bird aims to create the first-ever globally approved drug to tackle the transcription factor Myocyte Enhancer Factor 2C MEF2C deficiency within five years.
Annual Revenue
$201,500
Known Funders
3
Grants Received
5
Financial History
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $201,500 | $2,849 | $198,651 |
Top Funders
A D JOHNSON FOUNDATION
GLENVIEW, IL
$25,000 (2021)
$5,000 (2024)
KAREN AND JASON SUSSMAN FAMILY FOUNDATION
LONG GROVE, IL
$200 (2023)
KAREN AND JASON SUSSMAN FAMILY FOUNDATION
LONG GROVE, IL
$200 (2021)
KAREN AND JASON SUSSMAN FAMILY FOUNDATION
LONG GROVE, IL
$200 (2022)
Key Personnel
From 2024 IRS 990 filing
H
HIBA BHATTY
PRESIDENT
Officer
N
NOOR OSMAN
VICE PRESIDENT
Officer
N
NAJAH BHATTY
SECRETARY/TREASURER
Officer
J
JAMES KELLY
DIRECTOR
A
AHMED ELGHAZALY
DIRECTOR
Frequently Asked Questions
Other Nonprofits in Illinois
Northwestern Memorial HealthCare Group$10,054,188,947
ADVOCATE HEALTH AND HOSPITALS CORP$7,808,910,070
Feeding America$4,916,912,461
University of Chicago$4,613,831,972
Unlock Full Nonprofit Data
Sign up for free to access the complete funder list, financial history, program details, key personnel, and smart matching.